Several months back, many medical device makers painted a stark picture in which 50, 60 or 70% of their business dried up in a span of days, with elective surgeries largely shelved as the U.S. grappled with a pandemic few industries were prepared to handle.
But as second quarter earnings reports roll in, the sector's story is shifting.
The troughs in elective procedures seen in April moved to near-normal volumes come June, setting up device companies across the board to beat initial pandemic-era expectations.
|